MARKET

RADX

RADX

Radiopharm Theranostics Ltd
NASDAQ
4.020
-0.310
-7.16%
After Hours: 4.010 -0.01 -0.25% 19:54 06/26 EDT
OPEN
4.270
PREV CLOSE
4.330
HIGH
4.270
LOW
3.950
VOLUME
60.54K
TURNOVER
--
52 WEEK HIGH
16.25
52 WEEK LOW
3.620
MARKET CAP
47.49M
P/E (TTM)
-1.3094
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RADX last week (0615-0619)?
Weekly Report · 4d ago
Weekly Report: what happened at RADX last week (0608-0612)?
Weekly Report · 06/15 09:59
Weekly Report: what happened at RADX last week (0601-0605)?
Weekly Report · 06/08 09:56
This HC Wainwright & Co. Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday
Benzinga · 06/04 13:31
HC Wainwright & Co. Initiates Coverage On Radiopharm Theranostics with Buy Rating, Announces Price Target of $16
Benzinga · 06/04 11:15
Radiopharm initiated with a Buy at H.C. Wainwright
TipRanks · 06/04 10:10
Weekly Report: what happened at RADX last week (0525-0529)?
Weekly Report · 06/01 09:59
Weekly Report: what happened at RADX last week (0518-0522)?
Weekly Report · 05/25 10:02
More
About RADX
Radiopharm Theranostics Limited is an Australia-based clinical-stage radiotherapeutics company developing a platform of radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. The Company has a pipeline of highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer. The clinical program includes one Phase II and three Phase I trials in a variety of solid tumor cancers including lung, breast, and brain. Its technologies include Nano-mAbs, Pivalate, AVB6 Integrin, PSA-mAb, and PTPu. Nano-mAbs is a novel radiopharmaceutical platform made using genetic engineered camelid derived single domain antibodies (sdAb) labelled with a radioisotope of therapeutic radiation. Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate which utilizes the early steps of fatty acid oxidation.

Webull offers Radiopharm Theranostics Ltd stock information, including NASDAQ: RADX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RADX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RADX stock methods without spending real money on the virtual paper trading platform.